Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.74 -9.63 (-3.08%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Preferred Stock Liabilities (2011 - 2012)

Updated

Ligand Pharmaceuticals (LGND) posted Preferred Stock Liabilities of $8.3 million for Q1 2012, down 0.5% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Preferred Stock Liabilities (2011 - 2012) Analysis & Trends

At the end of FY2011, Ligand Pharmaceuticals' Preferred Stock Liabilities came in at $8.34 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Ligand Pharmaceuticals 6.22 Bn 2.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 8.30 Mn
Dec 31, 2011 8.34 Mn
API Access

Ligand Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=LGND&period=max&api_key=YOUR_API_KEY